Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jern

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Acta Anaesthesiologica Scandinavica|November 26, 2008
Impaired myocardial t-PA release in patients with coronary artery diseaseB Osterlund, S Jern, C Jern, et al.
Acta Anaesthesiologica Scandinavica|November 21, 1997
Aortic cross-clamping influences regional net release and uptake rates of tissue-type plasminogen activator in pigsH Seeman-Lodding, S Häggmark, C Jern, et al.
Acta Anaesthesiologica Scandinavica|July 17, 1999
Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP in the pigH Seeman-Lodding, S Häggmark, C Jern, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2000
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study InvestigatorsP M Okin, R B Devereux, S Jern, et al.
American Journal of Hypertension|August 11, 2001
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE StudyP M Okin, R B Devereux, S Jern, et al.
Acta Anaesthesiologica Scandinavica. Supplementum|January 1, 1997
Anesthesia and surgery influences regional net release and uptake rates of tissue-type plasminogen activator. An experimental study in the intact pigH Seeman-Lodding, B Biber, S Häggmark, et al.
Nordisk Medicin|January 1, 1983
[Review of new pharmacological treatment principles in hypertension]L Andrén, B Dahlöf, R Eggertsen, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH GroupS Jern, L Hansson, B Scherstén, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertensionB Dahlöf, L Andrén, R Eggertsen, et al.
Lakartidningen|March 9, 1983
[A review of recent pharmacological therapeutic principles in hypertension]L Andrén, B Dahlöf, R Eggertsen, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Acta Anaesthesiologica Scandinavica|November 26, 2008
Impaired myocardial t-PA release in patients with coronary artery diseaseB Osterlund, S Jern, C Jern, et al.
Acta Anaesthesiologica Scandinavica|November 21, 1997
Aortic cross-clamping influences regional net release and uptake rates of tissue-type plasminogen activator in pigsH Seeman-Lodding, S Häggmark, C Jern, et al.
Acta Anaesthesiologica Scandinavica|July 17, 1999
Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP in the pigH Seeman-Lodding, S Häggmark, C Jern, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2000
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study InvestigatorsP M Okin, R B Devereux, S Jern, et al.
American Journal of Hypertension|August 11, 2001
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE StudyP M Okin, R B Devereux, S Jern, et al.
Acta Anaesthesiologica Scandinavica. Supplementum|January 1, 1997
Anesthesia and surgery influences regional net release and uptake rates of tissue-type plasminogen activator. An experimental study in the intact pigH Seeman-Lodding, B Biber, S Häggmark, et al.
Nordisk Medicin|January 1, 1983
[Review of new pharmacological treatment principles in hypertension]L Andrén, B Dahlöf, R Eggertsen, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH GroupS Jern, L Hansson, B Scherstén, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertensionB Dahlöf, L Andrén, R Eggertsen, et al.
Lakartidningen|March 9, 1983
[A review of recent pharmacological therapeutic principles in hypertension]L Andrén, B Dahlöf, R Eggertsen, et al.
Pageof 14